{
  "title": "New Patient Outcome Assessed in Psoriasis Biologic Trial - Medscape",
  "url": "https://www.medscape.com/viewarticle/move-toward-assessing-well-being-psoriasis-biologic-2025a1000rgw",
  "summary": [
    {
      "type": "bullet",
      "text": "**KEY FINDING**: Study shows improvement in patient-reported outcomes 2 years post-treatment with tildrakizumab."
    },
    {
      "type": "bullet",
      "text": "**TACTICAL WIN [SHIP NOW]**: Integrate auto-reminders at day 3 to increase PRO assessment completion rates by 30%."
    },
    {
      "type": "bullet",
      "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: FDA requiring PRO data in trials within the next year, emphasizing global adoption."
    },
    {
      "type": "bullet",
      "text": "**CONCERN**: Self-selection bias may skew results toward healthier patients."
    }
  ],
  "model": "granite4:tiny-h"
}